Find a provider of ZOSTAVAX.


Here are some things you can do before you get ZOSTAVAX, the Shingles vaccine.

If you’re interested in receiving more information about ZOSTAVAX and Shingles, sign up below.

There is an error. Please see the highlighted sections and make sure the information is correct.

Please review the permission statement below and Merck’s privacy commitment to you.

The information you provide will be available to the Merck & Co., Inc. family of companies (collectively, “Merck”) and others working on behalf of Merck, and according to the same standards to provide the information and services you request. Personal information about you will not otherwise be disclosed for marketing purposes without your permission. Merck reviews personal information not only to provide the requested information and services but also to develop and offer additional services and communications that we believe our customers might find of interest. Merck also may use personal information to audit its resources for compliance and security purposes. For more information about how Merck protects personal information about you, please read Merck’s Internet Privacy Policy and Privacy Commitment to U.S. Patients, Consumers, and Caregivers.

ZOSTAVAX (Zoster Vaccine Live) is a vaccine that can help prevent Shingles in older adults.

ZOSTAVAX is given as a single shot. ZOSTAVAX cannot be used to treat Shingles, or the nerve pain that may follow Shingles, once you have it. Talk to your health care professional to see if ZOSTAVAX is right for you.

How would you like to get more information?

Congratulations! You've sumbitted a form.

This information will be used to analyze the program, to improve our understanding of vaccination trends, and to assess our communication effors. Your answers will not be used to identify you personally.



ZOSTAVAX is a vaccine used for adults 50 years of age or older to prevent Shingles (also known as zoster).

Important Safety Information

  • ZOSTAVAX does not protect everyone, so some people who get the vaccine may still get Shingles.
  • You should not get ZOSTAVAX if you are allergic to any of its ingredients, including gelatin or neomycin, have a weakened immune system, take high doses of steroids, or are pregnant or plan to become pregnant. You should not get ZOSTAVAX to prevent chickenpox.
  • Talk to your health care professional if you plan to get ZOSTAVAX (Zoster Vaccine Live) at the same time as PNEUMOVAX®23 (Pneumococcal Vaccine Polyvalent) because it may be better to get these vaccines at least 4 weeks apart.
  • Possible side effects include redness, pain, itching, swelling, hard lump, warmth, or bruising at the injection site, as well as headache.
  • ZOSTAVAX (Zoster Vaccine Live) contains a weakened chickenpox virus. Tell your health care professional if you will be in close contact with newborn infants, someone who may be pregnant and has not had chickenpox or been vaccinated against chickenpox, or someone who has problems with their immune system. Your health care professional can tell you what situations you may need to avoid.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit, or call 1-800-FDA-1088.

Please read the Patient Information and discuss it with your health care professional. The physician Prescribing Information also is available.

Download Adobe Acrobat Reader

To view PDF documents, you must have Adobe Acrobat Reader installed on your computer.

Enter information below:
*Indicates required field

  • *You must be 18 years or older to receive information:
  • Why is this required?

By providing your name, address, and other personal information above, and by clicking the “SUBMIT” button below, you agree to permit Merck, to use this information and materials associated with the ZOSTAVAX (Zoster Vaccine Live) program and information resources, services and communications about ZOSTAVAX via email or otherwise. Additionally, your information may be used for market research purposes.

At any time, you can request a copy of this permission, and that personal information about you be removed from the Merck contact list for ZOSTAVAX by calling
1-888-776-8364. Unless you change this selection sooner, your permission will expire 1 year after Merck no longer promotes ZOSTAVAX.

By clicking “SUBMIT” I am signing this form: